Epicure 50 mg is an antiepileptic medication primarily indicated for the treatment of partial-onset seizures in patients aged 4 years and older. It is available as an oral tablet, providing convenient and flexible dosing for long-term management of epilepsy. Epicure is often used as adjunctive therapy alongside other antiepileptic drugs (AEDs) in patients whose seizures are not fully controlled by monotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Adjunct Anti-Epileptic Drugs (AEDs)

Indications

Epicure 50 mg is indicated for:

• Partial-onset seizures in adults (≥16 years)

• Partial-onset seizures in pediatric patients (4–16 years), with weight-adjusted dosing

• Used as adjunct therapy when seizures are not controlled by a single AED

Epicure is not indicated for generalized seizures or seizure prophylaxis.

Pharmacology

Epicure contains Brivaracetam, a selective ligand for synaptic vesicle protein 2A (SV2A) in the brain. SV2A is involved in neurotransmitter release, particularly GABA, and plays a crucial role in epileptogenesis. By binding to SV2A, Epicure stabilizes neuronal activity, reducing abnormal excitability and seizure frequency. Additionally, Brivaracetam may modulate sodium channels, contributing further to its anticonvulsant activity.

Epicure is rapidly absorbed after oral administration, with high bioavailability and minimal interference from food. Peak plasma concentrations are typically reached within 1 hour, making it effective for consistent seizure control.

Dosage & Administration

Adults (≥16 years):

• Recommended starting dose: 50 mg twice daily (100 mg/day)

• Dose adjustment based on tolerability and response: 25–100 mg twice daily (50–200 mg/day)

Pediatric patients (4–16 years):

• Dose is weight-based and administered twice daily

• Oral tablets can be swallowed whole; can also be dispersed in water if needed

Administration notes:

• Take Epicure consistently at the same time each day

• Tablets can be taken with or without food

• Maintain adherence to avoid breakthrough seizures

Drug Interactions

• Rifampin: May decrease Brivaracetam plasma levels; dose adjustment may be needed

• Carbamazepine: May increase exposure to carbamazepine metabolite; monitor for toxicity

• Phenytoin: Plasma levels may increase; monitor phenytoin concentration

• Minimal interactions with other AEDs or oral contraceptives

• Caution with CNS depressants; may enhance sedation

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Known hypersensitivity to Brivaracetam or any tablet component

Side Effects

Common adverse reactions include:

• Somnolence / sedation

• Dizziness

• Fatigue

• Nausea or vomiting

Less frequent reactions may include headache, irritability, mood changes, or coordination difficulties. Most side effects are mild, transient, and resolve with continued use.

Pregnancy & Lactation

• Pregnancy: Only use if benefits outweigh risks; monitored in AED pregnancy exposure registries

• Lactation: Brivaracetam is excreted in milk in animal studies; caution is advised in nursing mothers

Precautions & Warnings

• Suicidal thoughts and behavior: Monitor patients for mood changes

• Neurological reactions: Advise patients not to drive until they know how the drug affects them

• Psychiatric effects: Monitor for irritability, aggression, or depression

• Withdrawal: Gradual taper recommended to avoid seizure recurrence

• Hepatic impairment: Dose adjustment recommended

• Renal impairment: No adjustment typically required

Storage Conditions

Store at 25°C, with excursions permitted between 15–30°C. Protect from light and moisture, and keep out of reach of children.

Mode of Action

Brivaracetam, the active ingredient, binds selectively to SV2A, reducing neurotransmitter release at overactive synapses. This action stabilizes neuronal excitability and suppresses seizure propagation. Sodium channel modulation may further enhance anticonvulsant effects.